A carregar...
Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway
BACKGROUND: VEGF signaling pathway inhibitor (anti-VEGF) therapy is associated with hypertension, but little is known about predisposing clinical characteristics. This study describes the real-world association between baseline clinical characteristics, blood pressure (BP) response, and survival in...
Na minha lista:
| Publicado no: | Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4293233/ https://ncbi.nlm.nih.gov/pubmed/25236375 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28972 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|